Defining cancer risk in dermatomyositis. Part I

Clinical and Experimental Dermatology

Volumn 34, Issue 4, 2009, Pages 451-455

  Madan, Vishal ^a   Chinoy, H ^a   Griffiths, C E M ^a   Cooper, R G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; DERMATOMYOSITIS; ELECTROMYOGRAPHY; MUSCLE BIOPSY; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

DERMATOMYOSITIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; NEOPLASMS; POLYMYOSITIS; RISK FACTORS;

EID: 65649085280     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03216.x     Document Type: Review

References (29)

1. Stertz G. Polymyositis. Berl Klin Wochenschr 1916 53 : 489.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975 292 : 344 7.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975 292 : 403 7.
4. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977 56 : 255 86. (Pubitemid 8130612)
5. Callen JP. Dermatomyositis and malignancy. Clin Rheum Dis 1982 8 : 369 81. (Pubitemid 12065394)
6. Buchbinder R, Hill CL. Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 2002 4 : 415 26.
7. Manchul LA, Jin A, Pritchard KI et al. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med 1985 145 : 1835 9. (Pubitemid 16221737)
8. Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ. Polymyositis- dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 1986 61 : 645 53. (Pubitemid 16029464)
9. Lyon MG, Bloch DA, Hollak B, Fries JF. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol 1989 16 : 1218 24. (Pubitemid 19260111)
10. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992 326 : 363 7.
11. Airio A, Pukkala E, Isomäki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995 22 : 1300 3.
12. Chow WH, Gridley G, Mellemkjaer L et al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995 6 : 9 13.
13. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001 85 : 41 5. (Pubitemid 32695714)
14. Banker BQ, Engel AG. The polymyositis and dermatomyositis syndromes. In : Myology: Basic and Clinical (Engel AG, Banker BQ, eds). New York : McGraw-Hill, 1986 : 1385 422.
15. Buchbinder R, Forbes A, Hall S et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001 134 : 1087 95. (Pubitemid 32552196)
16. Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994 21 : 1855 9. (Pubitemid 24312647)
17. Hill CL, Zhang Y, Sigurgeirsson B et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001 357 : 96 100. (Pubitemid 32094911)
18. Levine SM. Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 2006 18 : 620 4. (Pubitemid 44607417)
19. Marie I, Hatron P-Y, Levesque H et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 1999 78 : 139 47. (Pubitemid 29231141)
20. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 2001 144 : 825 31.
21. Ponyi A, Constantin T, Garami M et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci 2005 1051 : 64 71. (Pubitemid 41362733)
22. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986 80 : 329 32. (Pubitemid 16140792)
23. Basset-Seguin N, Roujeau JC, Gherardi R et al. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol 1990 126 : 633 7. (Pubitemid 20157677)
24. Gallais V, Crickx B, Belaich S. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. Ann Dermatol Venereol 1996 123 : 722 6. (Pubitemid 26401751)
25. Feldman D, Hochberg MC, Zizic TM, Stevens MB. Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol 1983 10 : 85 9.
26. Hunger RE, Durr D, Brand CU. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy. Dermatology 2001 202 : 123 6. (Pubitemid 32337162)
27. Urbano-Márquez A, Casademont J, Grau JM. Polymyositis/ dermatomyositis: the current position. Ann Rheum Dis 1991 50 : 191 5.
28. Kamel OW, van de Rijn M, Weiss LM et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993 328 : 1317 21. (Pubitemid 23131374)
29. Gunwardena H, North I, Wedderburn LR et al. Clinical associations of autoantibodies to p155/140k doublet protein in juvenile dermatomyositis. Rheumatology 2008 24 : 324 8.